Concepedia

Publication | Open Access

Efficacy of Vedolizumab for Refractory Pouchitis of the Ileo-anal Pouch: Results From a Multicenter US Cohort

DOIFull Paper Access

76

Citations

23

References

2019

Year

Martin Gregory, Kimberly N. Weaver, Patrick Hoversten, Stephen B. Hicks, Devin Patel, Matthew A. Ciorba, Alexandra Gutierrez, Poonam Beniwal‐Patel, Sowmya Palam, Gaurav Syal,
Inflammatory Bowel Diseases

Abstract

Vedolizumab is safe and effective in the management of CD of the pouch and chronic pouchitis. Further studies are needed to compare vedolizumab with other biologic therapies for pouchitis and CD of the pouch.

References

YearCitations

Page 1